A drug no longer needs to be a tangible object, according to panelist at the BIO 2018 convention in Boston. The way the pharma industry looks at medication is evolving and may be including new tech-focused treatments, such as digital therapeutics.
from MobiHealthNews https://ift.tt/2Jk3b5i
Subscribe to:
Post Comments (Atom)
Rose
0 comments:
Post a Comment